NasdaqCM - Nasdaq Real Time Price
USD
Cardiol Therapeutics Inc. (CRDL)
2.2250
+0.2250
(+11.25%)
As of 2:01:46 PM EDT. Market Open.
Loading chart for CRDL
- Previous Close
2.0000 - Open
2.0498 - Bid 1.5900 x 200
- Ask 2.5800 x 200
- Day's Range
2.0200 - 2.2400 - 52 Week Range
0.8800 - 2.2400 - Volume
2,777,742 - Avg. Volume
814,811 - Market Cap (intraday)
259.93M - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2500 - Earnings Date (est.) Nov 12, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.89
Recent News
View More
Performance Overview
Trailing total returns as of 8/26/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
CRDL
129.86%
S&P/TSX Composite index (^GSPTSE)
15.87%
1-Year Return
CRDL
93.48%
S&P/TSX Composite index (^GSPTSE)
30.29%
3-Year Return
CRDL
124.97%
S&P/TSX Composite index (^GSPTSE)
86.15%
5-Year Return
CRDL
30.25%
S&P/TSX Composite index (^GSPTSE)
80.08%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 8/25/2026
-
Market Cap
232.94M
-
Enterprise Value
214.17M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
13.38
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-90.92%
-
Return on Equity (ttm)
-190.18%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-34.08M
-
Diluted EPS (ttm)
-0.2500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
26.08M
-
Total Debt/Equity (mrq)
0.44%
-
Levered Free Cash Flow (ttm)
-15.48M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
2.2250
+11.25%
Mkt Cap
259.93M
Industry
Drug Manufacturers—Specialty & Generic
0.7600
+2.40%
Mkt Cap
23.792M
Industry
Drug Manufacturers—Specialty & Generic
0.8934
-6.78%
Mkt Cap
247.567M
Industry
Drug Manufacturers—Specialty & Generic
78.75
-1.81%
Mkt Cap
6.059B
Industry
Drug Manufacturers—Specialty & Generic
0.7869
-2.86%
Mkt Cap
83.222M
Industry
Drug Manufacturers—Specialty & Generic
Mkt Cap
undefined
-
Industry
-
4.2950
-2.16%
Mkt Cap
709.706M
Industry
Drug Manufacturers—Specialty & Generic
6.09
+1.16%
Mkt Cap
445.897M
Industry
Drug Manufacturers—Specialty & Generic
0.0002
+100.00%
Mkt Cap
2.779M
Industry
Drug Manufacturers—Specialty & Generic
61.75
-2.06%
Mkt Cap
1.765B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
